These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 2704582)
21. Elevated IRT levels in African-American infants: implications for newborn screening in an ethnically diverse population. Giusti R; Pediatr Pulmonol; 2008 Jul; 43(7):638-41. PubMed ID: 18500736 [TBL] [Abstract][Full Text] [Related]
22. Initial regional evaluation of the Cystic Fibrosis Newborn Screening Program: data from the Mediterranean coast of Turkey. Başaran AE; Başaran A; Kocacik DF; Alper Ö; Acican D; Bingöl A Turk J Med Sci; 2019 Dec; 49(6):1655-1661. PubMed ID: 31655510 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. Parad RB; Comeau AM J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789 [TBL] [Abstract][Full Text] [Related]
24. Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers. Castellani C; Picci L; Scarpa M; Dechecchi MC; Zanolla L; Assael BM; Zacchello F Am J Med Genet A; 2005 Jun; 135(2):142-4. PubMed ID: 15832355 [TBL] [Abstract][Full Text] [Related]
25. Experience with neonatal screening for cystic fibrosis in New Zealand using measurement of immunoreactive trypsinogen. Wesley AW; Smith PA; Elliott RB Aust Paediatr J; 1989 Jun; 25(3):151-5. PubMed ID: 2764837 [TBL] [Abstract][Full Text] [Related]
26. Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening. Kay DM; Langfelder-Schwind E; DeCelie-Germana J; Sharp JK; Maloney B; Tavakoli NP; Saavedra-Matiz CA; Krein LM; Caggana M; Kier C; Pediatr Pulmonol; 2015 Aug; 50(8):771-80. PubMed ID: 26098992 [TBL] [Abstract][Full Text] [Related]
27. Prospective and parallel assessments of cystic fibrosis newborn screening protocols in the Czech Republic: IRT/DNA/IRT versus IRT/PAP and IRT/PAP/DNA. Krulišová V; Balaščaková M; Skalická V; Piskáčková T; Holubová A; Paděrová J; Křenková P; Dvořáková L; Zemková D; Kračmar P; Chovancová B; Vávrová V; Stambergová A; Votava F; Macek M Eur J Pediatr; 2012 Aug; 171(8):1223-9. PubMed ID: 22581207 [TBL] [Abstract][Full Text] [Related]
29. Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis. Sarles J; Berthézène P; Le Louarn C; Somma C; Perini JM; Catheline M; Mirallié S; Luzet K; Roussey M; Farriaux JP; Berthelot J; Dagorn JC J Pediatr; 2005 Sep; 147(3):302-5. PubMed ID: 16182665 [TBL] [Abstract][Full Text] [Related]
30. Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots. Crossley JR; Smith PA; Edgar BW; Gluckman PD; Elliott RB Clin Chim Acta; 1981 Jun; 113(2):111-21. PubMed ID: 7249357 [TBL] [Abstract][Full Text] [Related]
31. Screening for cystic fibrosis: a four year regional experience. Roberts G; Stanfield M; Black A; Redmond A Arch Dis Child; 1988 Dec; 63(12):1438-43. PubMed ID: 3232990 [TBL] [Abstract][Full Text] [Related]
32. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years. Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332 [TBL] [Abstract][Full Text] [Related]
33. False-positive results in neonatal screening for cystic fibrosis based on a three-stage protocol (IRT/DNA/IRT): Should we adjust IRT cut-off to ethnic origin? Cheillan D; Vercherat M; Chevalier-Porst F; Charcosset M; Rolland MO; Dorche C J Inherit Metab Dis; 2005; 28(6):813-8. PubMed ID: 16435172 [TBL] [Abstract][Full Text] [Related]
38. Newborn screening for cystic fibrosis in Victoria: 10 years' experience (1989-1998). Massie RJ; Olsen M; Glazner J; Robertson CF; Francis I Med J Aust; 2000 Jun; 172(12):584-7. PubMed ID: 10914103 [TBL] [Abstract][Full Text] [Related]
39. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience. Sands D; Zybert K; Mierzejewska E; Ołtarzewski M Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066 [TBL] [Abstract][Full Text] [Related]
40. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations. Padoan R; Bassotti A; Seia M; Corbetta C Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]